26.06USD-1.66%Mkt Cap: 1.50B $P/E: —2d ago
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.50B $
Enterprise Value2.87B $
Revenue (TTM)2.30B $
Gross Profit1.35B $
Net Income (TTM)-1.18B $
Revenue/Share40.07 USD
Last Price26.06 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees7.8K
CountryUS
SectorIndustrials
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)6.52
PEG3.45
EV/EBITDA7.57
EV/Revenue1.25
P/S0.66
P/B1.02
EPS (TTM)-19.04
EPS (Forward)4.01
52W Range
19.1446% of range34.28
52W High34.28 USD
52W Low19.14 USD
Profitability
Gross Margin59.84%
Oper. Margin4.18%
EBITDA Margin16.51%
Profit Margin-52.69%
ROE-79.51%
ROA-30.89%
Growth
Revenue Growth3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF217.29M $
CapEx (TTM)197.38M $
FCF Margin8.08%
FCF Yield12.35%
Net Debt1.36B $
Net Debt/EBITDA3.58
Balance Sheet
Debt/Equity0.93
Current Ratio1.99
Quick Ratio0.74
Book Value/Sh25.61 USD
Cash/Share0.2180 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split581:1000
Split DateApr 5, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)40.83 USD
Upside (mean)+56.7%
Target Range28.00 USD – 55.00 USD
$28.00+56.7% to mean$55.00
# Analysts12
Ownership
Shares Out.57.67M
Float52.79M
Insiders1.62%
Institutions124.96%
Short Interest
Short Ratio7.5d
Short % Float17.65%
Short % Out.14.81%
Shares Short8.54M
Short (prev mo.)9.50M
Technical
SMA 5025.11 (+3.8%)
SMA 20025.12 (+3.7%)
Beta1.45
S&P 52W Chg18.16%
Avg Vol (30d)950.19K
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)48.9
MACD-0.0958
MACD Signal0.2719
MACD Hist.-0.3677
BB Upper31.96 USD
BB Middle27.38 USD
BB Lower22.80 USD
BB Width33.45%
ATR (14)1.616 USD
Vol Ratio (20d)0.45x